Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

NCT01345019 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma Patients

NCT05802992 ·Status: UNKNOWN ·Phase: PHASE3

Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma

NCT00216151 ·Status: TERMINATED ·Phase: PHASE2

Technology Platform and System Construction of Clinical Evaluation Studies on New Drugs of Hematological Malignancy

NCT01250808 ·Status: AVAILABLE

Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy

NCT00972959 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma

NCT01572688 ·Status: UNKNOWN ·Phase: NA

Study of Subcutaneous and Intravenous Velcade in Combination With Dexamethasone in Chinese Subjects With Relapsed and Refractory Multiple Myeloma

NCT02811978 ·Status: COMPLETED ·Phase: PHASE3

Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma

NCT00263484 ·Status: COMPLETED ·Phase: PHASE2

Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders

NCT00258258 ·Status: TERMINATED ·Phase: PHASE1

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

NCT00171925 ·Status: TERMINATED ·Phase: PHASE3

Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma Who Participated in CC-5013-MM021 for at Least 1 Year

NCT02348528 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma

NCT01249690 ·Status: UNKNOWN ·Phase: PHASE4

Modified Bortezomib-based Combination Therapy for Multiple Myeloma

NCT02559154 ·Status: UNKNOWN ·Phase: PHASE4

Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma

NCT01234129 ·Status: COMPLETED

A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma

NCT05860036 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer

NCT00760370 ·Status: COMPLETED ·Phase: PHASE2

Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients

NCT05855122 ·Status: UNKNOWN ·Phase: PHASE4

Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed/Refractory Multiple Myeloma

NCT05857982 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of NINLARO® in Chinese Adults With Multiple Myeloma

NCT05013190 ·Status: ACTIVE_NOT_RECRUITING

Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant

NCT00288028 ·Status: COMPLETED ·Phase: PHASE1

A Study of PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma

NCT01852799 ·Status: COMPLETED ·Phase: PHASE2

Tolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma.

NCT02086942 ·Status: UNKNOWN ·Phase: PHASE2

Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma

NCT03029234 ·Status: COMPLETED ·Phase: PHASE3

This is an Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Treatment With CT0591CP in Patients With Relapsed and/or Refractory Multiple Myeloma.

NCT05486975 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell Transplant

NCT00619684 ·Status: COMPLETED ·Phase: PHASE2